Arcus Biosciences, Inc. · NYSE:RCUS

Gilead Sciences, Inc. reported a 25.60% stake in Arcus Biosciences, Inc. (Schedule 13D/A)

Event Nov 3, 2025 · Filed Nov 5, 2025

Gilead Sciences, Inc. reported a 25.60% stake in Arcus Biosciences, Inc., 31,424,760 shares, with active intent on Nov 3, 2025. Filed Nov 5, 2025 (Schedule 13D/A).

Stake
25.60%
Shares
31,424,760
Intent
Active
What changed
Stake changed

The filing in full

HolderStakeShares
GILEAD SCIENCES, INC.25.60%31,424,760

Source

View original at SEC

Related